Results 211 to 220 of about 2,934,165 (348)

Law′s Dilemma: Validating Complementary and Alternative Medicine and the Clash of Evidential Paradigms [PDF]

, 2010
Ireh Iyioha
openalex   +1 more source

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

Molecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié, Umberto Malapelle, Catherine Alix‐Panabières, Claus Lindbjerg Andersen, Sandra Chlebowski, Vivien Lake, Caroline Lacoux, Virginie Lespinet‐Fabre, Olivier Bordone, Simon Heeke, Christophe Bontoux, Ellen Heitzer, Klaus Pantel, Paul Hofman   +13 more
wiley   +1 more source

Translation and cultural adaptation of the I-CAM-Q: the first Hungarian version for assessing complementary and alternative medicine use. [PDF]

BMC Complement Med Ther
Rák T, Hegedűs A, Molnár E, Csutak A.
europepmc   +1 more source

Complementary and alternative medicine: Road maps to information.

, 1998
Glennis Zilm
openalex  

Alternative and complementary medicine: A source of improved therapies for asthma? A challenge for redefining the specialty? [PDF]

, 2000
Renata J.M. Engler
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

The Quality of Life in Kidney Transplant Recipients and Its Relation With the Use of Complementary and Alternative Medicine: A Cross-Sectional Study. [PDF]

Health Sci Rep
Dehghan M, Aminizadeh M, Tajedini H, Mohebi Rad M, Abazari L, Tehrany S, Tahmasbi E, Rahiminezhad M, Zakeri MA.   +8 more
europepmc   +1 more source

The Emperor's New Clothes: Media Representations Of Complementary and Alternative Medicine: 1990-2005 [PDF]

, 2015
Barbara Rowlands
openalex  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Comprehensive overview of alternative medicine in the treatment of ankylosing spondylitis: Symptoms, pathogenesis, diagnosis and treatments (Review). [PDF]

Biomed Rep
Park SY, Kwon MS, So S, Choi Y, Kim DY, Kim MH.   +5 more
europepmc   +1 more source